PRE
Prenetics Global Limited
Consumer Defensive — Packaged Foods
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand. It also operates a consumer genetic testing brand in CircleDNA leveraging sequencing technology to deliver personalized reports across various categories. The company was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Strong Buy
1.0 / 5
5 analysts
$21.95
$-1.18 (-5.10%)
Target:
$31.00
(41.2%)
Price History
52-Week Range
Sign in to add PRE to a watchlist or set price alerts.
Fundamentals
| Market Cap | $304.14M |
| P/E Ratio (TTM) | - |
| Forward P/E | -26.31 |
| EPS (TTM) | $-3.63 |
| Dividend Yield | - |
| Profit Margin | -41.99% |
| Revenue Growth | 107.70% |
| ROE | -40.77% |
| Debt/Equity | 0.38 |
| Recommendation | Strong Buy 1.0 |
| Analyst Target | $31.00 |
| Analysts | 5 |
| Next Earnings | Aug 18, 2026 BMO |
| Indexes | - |
Technical Indicators
| RSI (14) | 42.0 |
| Beta | 0.25 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $23.63 |
| 52-Week Low | $7.18 |
| 50-Day Avg | $18.46 |
| 200-Day Avg | $16.88 |
| Avg Volume | 209.7K |
| Volume | 60.7K |
Performance Analysis
BULLISHPRE shows predominantly bullish signals based on its fundamentals and technicals.
+
Showing strength at 90% of its 52-week range.
~
RSI at 42.0 is in neutral territory.
+
Price is above both the 50-day and 200-day moving averages — strong uptrend.
+
Strong revenue growth of 107.7% year-over-year.
-
Operating at a loss with -42.0% margin.
+
Wall Street consensus is "Strong Buy" from 5 analysts.
+
Average analyst target of $31.00 implies 41.2% upside.
Recent News
Loading news...
Last updated: Jul 02, 2026 13:27 UTC
Back to Screener Export Report